Novelix Pharmaceuticals Ltd — Important, 23-10-2025: Company Update

Novelix Pharmaceuticals' Board has approved the allotment of 16.61 lakh equity shares, each at an issue price of Rs. 20 (including a Rs. 10 premium). These shares were issued to 19 investors, encompassing both promoter and non-promoter groups, who converted their warrants. The company received Rs. 2.49 crore from this conversion. This allotment is part of the original 1.5 crore warrant issuance. Consequently, the company's paid-up equity capital has increased from Rs. 14.48 crore to Rs. 16.14 crore, expanding the total outstanding shares and bringing in fresh capital.